Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology

Can ARSACS Start in Adulthood? Late-Onset Symptoms

At a Glance

While ARSACS is typically diagnosed in childhood, it can develop in adulthood if a patient has specific genetic mutations that allow for partial sacsin protein function. Adult-onset ARSACS often lacks classic muscle spasticity and is diagnosed using genetic testing and specific eye scans.

Yes, it is entirely possible to be diagnosed with ARSACS as an adult without having had noticeable symptoms as a child. While “classic” ARSACS is identified by delayed walking in toddlers [1], “atypical” or late-onset ARSACS is a well-documented variation of the condition [2]. If you spent years experiencing intense confusion or misdiagnosis before finally being identified, your experience is unfortunately very common for adult-onset patients.

Why Do Symptoms Start Later in Life?

ARSACS is caused by variations (mutations) in the SACS gene, which provides instructions for making a protein called sacsin. Sacsin is crucial for the health and function of your nerve cells.

In classic early-onset ARSACS, genetic mutations lead to an almost total loss of the sacsin protein from birth [3][4]. However, in atypical late-onset cases, the severity of the specific mutation (its pathogenicity) can be lower [5]. Researchers have found that certain specific SACS gene variants—such as specific missense mutations (a single-letter typo in your DNA code)—may allow for some partial sacsin protein function or stability [5][2].

This small amount of working protein may be enough to protect your nervous system throughout childhood. It is only when the cumulative stress on your nerve cells reaches a certain threshold over decades that symptoms finally begin to manifest [2].

How Adult-Onset ARSACS Differs from the Classic Form

The classic triad of ARSACS symptoms in children involves ataxia (loss of balance and coordination), spasticity (stiff, rigid muscles), and peripheral neuropathy (nerve damage in the arms and legs).

If you developed symptoms as an adult, your clinical presentation might look quite different from this classic triad:

  • Lack of Spasticity: Many late-onset patients present with ataxia and polyneuropathy but do not experience the muscle spasticity that defines childhood cases [6][7].
  • Gait Instability and Weakness: Symptoms often begin as progressive unsteadiness when walking, or subtle weakness in the lower legs, rather than the severe early motor delays seen in classic ARSACS [2][7].
  • Missing MRI Clues: In early-onset ARSACS, brain MRIs frequently show characteristic “stripes” in the pons (a part of the brainstem). In adult-onset cases, these classic brain-imaging manifestations may be completely absent, making the condition incredibly difficult for general neurologists to identify [6][7].

A Highly Specific Clue: The Eyes

Even when physical symptoms and brain MRIs are atypical, most people with ARSACS—regardless of their age of onset—share one highly specific feature: a thickening of the retinal nerve fiber layer (RNFL) [8][9]. This is an abnormality in the back of the eye that does not typically affect your vision but can be easily detected with a non-invasive eye scan called Optical Coherence Tomography (OCT). If your doctors were puzzled by your physical symptoms, an eye scan or genetic testing was likely the key to confirming your diagnosis [8][4].

Looking Forward

Being diagnosed with a rare genetic condition as an adult can be overwhelming, but understanding that your late-onset form is biologically distinct can be reassuring. Because the disease manifests later in life, researchers suggest that late-onset ARSACS may progress at a different rate and have an extended “therapeutic window” [2]. This means you may have more time to intervene with targeted physical therapy, symptom management (such as orthotic devices for gait instability or medications for neuropathy), and potential future treatments compared to those who develop the condition in infancy.

Common questions in this guide

Why do some people with ARSACS only develop symptoms as adults?
Adult-onset ARSACS often occurs when a person has a specific missense mutation in the SACS gene that allows for partial sacsin protein function. This small amount of working protein can protect the nervous system during childhood, meaning symptoms only manifest after decades of cumulative stress on the nerve cells.
How do the symptoms of late-onset ARSACS differ from the childhood form?
Adults with late-onset ARSACS often present with progressive gait instability, unsteadiness, and peripheral neuropathy, but they frequently lack the muscle spasticity seen in early childhood cases. Additionally, adults may not show the classic striped pattern on brain MRIs typically associated with the early-onset form.
If my brain MRI was normal, how can doctors diagnose adult-onset ARSACS?
Even without classic brain imaging clues, most people with ARSACS have a distinct thickening of the retinal nerve fiber layer in the back of the eye. Doctors can detect this using a non-invasive scan called Optical Coherence Tomography (OCT), which, along with genetic testing, helps confirm the condition.
Will my late-onset ARSACS progress differently than the childhood version?
Researchers believe that late-onset ARSACS may progress at a different rate than the early-onset form. Because symptoms appear later in life, you may have an extended therapeutic window to manage the condition with targeted physical therapy and symptom management strategies.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific SACS gene mutations were identified in my genetic testing, and are they typically associated with milder or late-onset presentations?
  2. 2.Has my medical team performed an Optical Coherence Tomography (OCT) scan of my eyes to establish a baseline for retinal nerve fiber layer thickening?
  3. 3.Since I do not have classic spasticity, how should we tailor my physical therapy to focus on my specific symptoms like unsteadiness or neuropathy?
  4. 4.What is the expected rate of progression for someone diagnosed at my age compared to the childhood-onset form?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Spastic ataxias.

    Bereznyakova O, Dupré N

    Handbook of clinical neurology 2018; (155()):191-203 doi:10.1016/B978-0-444-64189-2.00012-3.

    PMID: 29891058
  2. 2

    Novel SACS Variants not Recorded in ClinVar Identified in a Chinese Patient with Late-Onset Hereditary Neuropathy: a Case Report and Literature Review.

    Chen M, Wang X, Ye X, et al.

    Cerebellum (London, England) 2025; (24(6)):160 doi:10.1007/s12311-025-01909-9.

    PMID: 41021113
  3. 3

    Assessment of Sacsin Turnover in Patients With ARSACS: Implications for Molecular Diagnosis and Pathogenesis.

    Longo F, De Ritis D, Miluzio A, et al.

    Neurology 2021; (97(23)):e2315-e2327 doi:10.1212/WNL.0000000000012962.

    PMID: 34649874
  4. 4

    Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix-Saguenay.

    De Ritis D, Ferrè L, De Winter J, et al.

    Brain communications 2024; (6(4)):fcae243 doi:10.1093/braincomms/fcae243.

    PMID: 39091421
  5. 5

    A novel homozygous SACS mutation identified by whole exome sequencing-genotype phenotype correlations of all published cases.

    Xiromerisiou G, Dadouli K, Marogianni C, et al.

    Journal of molecular neuroscience : MN 2020; (70(1)):131-141 doi:10.1007/s12031-019-01410-z.

    PMID: 31701440
  6. 6

    SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

    Vill K, Müller-Felber W, Gläser D, et al.

    Human genetics 2018; (137(11-12)):911-919 doi:10.1007/s00439-018-1952-6.

    PMID: 30460542
  7. 7

    Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay without Spasticity.

    Aida I, Ozawa T, Fujinaka H, et al.

    Internal medicine (Tokyo, Japan) 2021; (60(24)):3963-3967 doi:10.2169/internalmedicine.7401-21.

    PMID: 34121011
  8. 8

    Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

    Parkinson MH, Bartmann AP, Clayton LMS, et al.

    Brain : a journal of neurology 2018; (141(4)):989-999 doi:10.1093/brain/awy028.

    PMID: 29538656
  9. 9

    Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.

    Rezende Filho FM, Bremner F, Pedroso JL, et al.

    Movement disorders : official journal of the Movement Disorder Society 2021; (36(9)):2027-2035 doi:10.1002/mds.28612.

    PMID: 33893680

This page provides educational information about late-onset ARSACS. It does not replace professional medical advice, and you should always consult your neurologist or genetic counselor regarding your specific diagnosis and symptoms.

Get notified when new evidence is published on Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.